| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824111 | Biochemical Pharmacology | 2010 | 11 Pages |
Keywords
GPRC6ApTHGFREGFTMDVDRADPKDFGF-23DcTNKFKDOQIFHHX-linked hypophosphatemiaPHEXCalcimimeticXLHTiOPHPTFDACao2+cTALPLCmGluRCaSRBMDJnkEC50ERKECDSecondary hyperparathyroidism1,25(OH)2D31,25-dihydroxyvitamin D3c-Jun N-terminal kinaseMAPKKidney Disease Outcomes Quality InitiativeUS Food and Drug AdministrationGamma aminobutyric acidNational Kidney Foundationchronic kidney diseaseESRD یا end stage renal diseaseautosomal dominant polycystic kidney diseaseBone mineral densitydistal convoluted tubuleextracellular domaintransmembrane domainParathyroid cancerepidermal growth factorextracellular calcium concentrationphospholipase CFibroblast growth factor-23end stage renal diseaseNeonatal severe hyperparathyroidismCKDGlomerular filtration rateparathyroid hormonePrimary hyperparathyroidismFamilial hypocalciuric hypercalcemiaParathyroidmitogen-activated protein kinasetumor-induced osteomalaciaRenal transplantationextracellular signal-regulated kinaseGABACalcium-sensing receptorVitamin D receptorMetabotropic glutamate receptor
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Edward M. Brown,